Vivet Therapeutics, a clinical-stage biotech company dedicated to developing gene therapy
Vivet Therapeutics BD Director, Thomas Daniel-Robin
Vivet Therapeutics CEO, Jean-Philippe Combal, will be participating to a panel during 2021 World Orphan Drug Congress Europe in Barcelona (Nov 15-18).
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
Vivet CDO, Anne Douar, will be presenting
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
Jean-Philippe Combal, Vivet CEO, will be attending a panel during the Cell & Gene Meeting on the Med - virtual, organized by the ARM on April 6-9, 2021. The panel, "TRENDS AND CHALLENGES IN GENE THERAPY IN EUROPE", will be held on April 7, 3-4pm CET.
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2020 London Healthcare Conference on November 17-19.
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation
VIVET ATTENDING CHARDAN'S 4th ANNUAL GENETIC MEDICINES CONFERENCE